ZA200710799B - Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethylphenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide - Google Patents
Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethylphenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideInfo
- Publication number
- ZA200710799B ZA200710799B ZA200710799A ZA200710799A ZA200710799B ZA 200710799 B ZA200710799 B ZA 200710799B ZA 200710799 A ZA200710799 A ZA 200710799A ZA 200710799 A ZA200710799 A ZA 200710799A ZA 200710799 B ZA200710799 B ZA 200710799B
- Authority
- ZA
- South Africa
- Prior art keywords
- methyl
- ylamino
- trifluoromethylphenyl
- benzamide
- imidazol
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70140505P | 2005-07-20 | 2005-07-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200710799B true ZA200710799B (en) | 2008-11-26 |
Family
ID=39859562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200710799A ZA200710799B (en) | 2005-07-20 | 2007-12-12 | Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethylphenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101228150B (en) |
ZA (1) | ZA200710799B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2262793T3 (en) * | 2008-11-05 | 2012-10-15 | Teva Pharma | Crystalline forms of nilotinib-hci |
AR086913A1 (en) * | 2011-06-14 | 2014-01-29 | Novartis Ag | 4-METIL-3 - [[4- (3-PIRIDINIL) -2-PIRIMIDINIL] -AMINO] -N- [5- (4-METHYL-1H-IMIDAZOL-1-IL) -3- (TRIFLUORO-METIL) -FENIL] -BENZAMIDA AMORFA, FORM OF DOSAGE THAT CONTAINS AND METHOD TO PREPARE |
CN106496193A (en) * | 2016-09-13 | 2017-03-15 | 福格森(武汉)生物科技股份有限公司 | A kind of preparation method of high-purity nilotinib |
CN113214225B (en) * | 2020-01-21 | 2023-12-22 | 江苏希迪制药有限公司 | Method for preparing nilotinib Shan Yansuan salt dihydrate crystal form A |
-
2006
- 2006-07-18 CN CN200680026434.2A patent/CN101228150B/en active Active
-
2007
- 2007-12-12 ZA ZA200710799A patent/ZA200710799B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101228150B (en) | 2014-10-15 |
CN101228150A (en) | 2008-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL214659A0 (en) | Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide | |
IL187787A0 (en) | Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide | |
HK1219295A1 (en) | Derivation of embryonic stem cells | |
IL197420A0 (en) | Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1- | |
IL180546A0 (en) | Novel piperidine derivative for the treatment of depression | |
IL183380A0 (en) | Crystalline forms of linezolid intermediate | |
ZA200710799B (en) | Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethylphenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide | |
ZA200903981B (en) | Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy-3-bromo-6-methyl-2-oxopyridin-1(2h)-yl)-n,4-dimethyl-benzamide | |
ZA200710457B (en) | Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoro-methyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide | |
SI1814858T1 (en) | Novel crystalline forms of nelfinavir mesylate | |
GB0522066D0 (en) | Timing controller | |
GB0703687D0 (en) | Novel crystalline forms of 6alpha, 9alpha-difluoro-11beta hydroxy-16al-pha-methyl-3-oxo-17alpha-propionyloxy-androsta-1, 4-diene-17beta-carbyoxylic acid | |
GB2426841B (en) | Memory controller | |
GB0519275D0 (en) | Manufacture of Ifenprodil | |
GB0512717D0 (en) | Mouth piece compensation |